You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新開源(300109.SZ):子公司擬售NKY US 100%股權 對價初步預計約為3.43億美元
格隆匯 08-02 08:20

格隆匯8月2日丨新開源(300109.SZ)公佈,2021年8月1日,公司、新開源生物、NKY US以及Abcam、Abcam US簽署了《股份購買協議》。根據《股份購買協議》,公司子公司新開源生物將以現金方式向Abcam子公司Abcam US出售其持有的NKY US的100%股權。該次交易完成後,新開源生物將不再持有NKY US股權。

NKY US為公司在美國特拉華州設立的間接持有BioVision的特殊目的公司,主要資產為BioVision的100%股權。NKY US 100%股權估算交易價格約為3.43億美元。

該次交易將為公司進一步實施“消費類特種化學品平台+健康醫療服務平台”雙平台長期發展戰略提供資金支持,同時可以有效降低疫情等因素對跨境管理與公司經營可能造成的風險,使公司能夠進一步聚集資金資源和管理資源,聚焦醫療健康產業。

自2019年公司收購BioVision以來,BioVision經營情況良好,為公司精準醫療業務板塊的發展做出了較為明顯的貢獻。儘管BioVision盈利情況良好,不存在商譽減值跡象,但商譽仍為資本市場以及投資者對公司的重要顧慮。該次交易完成後,公司的商譽將大幅降低,未來公司所面臨的商譽減值風險將大幅降低。

另外,通過該次交易標的資產的置出,公司將收回大額現金,對價可部分用於償還上市公司債務,從而達到改善資產負債率、優化資產結構的目的;並可用於支持醫療健康產業的持續發展,提升上市公司競爭力,維護上市公司及股東利益,為公司的持續發展提供有力保障。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account